| NCT Number | NCT06614179 |
| Lead Sponsor | Xiangdong Cheng |
| Conditions | Abdominal Neoplasm |
| Enrollment | 100,000 participants |
| Start Date | 2024-07-01 |
| Primary Completion | 2029-12-31 (estimated) |
| Study Completion | 2029-12-31 (estimated) |
| Updated on ClinicalTrials.gov | 2024-09-26 |